Toronto Dominion Bank Sells 12,510 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Toronto Dominion Bank lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 181,492 shares of the medical equipment provider's stock after selling 12,510 shares during the quarter. Toronto Dominion Bank owned about 0.05% of Intuitive Surgical worth $89,162,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares during the last quarter. LGT Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after buying an additional 54 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $33,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at $37,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Up 1.1 %

ISRG stock traded up $5.72 during trading on Wednesday, reaching $543.81. 496,168 shares of the stock were exchanged, compared to its average volume of 1,439,836. The firm's 50 day moving average is $518.23 and its 200 day moving average is $476.59. Intuitive Surgical, Inc. has a twelve month low of $314.38 and a twelve month high of $556.23. The firm has a market cap of $193.69 billion, a P/E ratio of 87.40, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 270 shares of the business's stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Amy L. Ladd sold 450 shares of the business's stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now owns 821 shares of the company's stock, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 50,755 shares of company stock valued at $26,273,943. 0.90% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on ISRG. Raymond James increased their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research note on Monday, October 14th. Citigroup raised their price target on Intuitive Surgical from $567.00 to $640.00 and gave the company a "buy" rating in a report on Wednesday. Stifel Nicolaus increased their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. BTIG Research increased their target price on Intuitive Surgical from $535.00 to $561.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Finally, Leerink Partners increased their target price on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $550.28.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.